Evidence map›Paper›PMID 38472674›Full record

ArticleAnnals of surgical oncology2024

Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible.

Pim B Olthof, Joris I Erdmann, Ruslan Alikhanov, Ramón Charco, Alfredo Guglielmi, Jeroen Hagendoorn, Abdul Hakeem, Frederik J H Hoogwater, William R Jarnagin, Geert Kazemier and 18 more

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Outcomes of Liver Transplant Versus Partial Hepatectomy for Perihilar Cholangiocarcinoma Patients Requiring Arterial Reconstruction.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  5. Changing concepts in perihilar cholangiocarcinoma resections and surgery.International journal of surgery (London, England) · 2026
    Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Review
  11. [Klatskin tumors-differentiated surgical treatment].Chirurgie (Heidelberg, Germany) · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Pim B OlthofDepartment of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands. p.olthof@erasmusmc.nl.
Joris I ErdmannDepartment of Surgery, Amsterdam UMC, Amsterdam, The Netherlands.
Ruslan AlikhanovDepartment of Liver and Pancreatic Surgery, Department of Transplantation, Moscow Clinical Scientific Centre, Moscow, Russia.
Ramón CharcoDepartment of HBP Surgery and Transplantation, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain.
Alfredo GuglielmiDivision of General Surgery, Department of Surgery, Unit of Hepato-Pancreato-Biliary Surgery, University of Verona Medical School, Verona, Italy.
Jeroen HagendoornDepartment of Surgical Oncology, University Medical Centre/Utrecht University, Utrecht, The Netherlands.
Abdul HakeemDivision of Surgery, Department of Hepatobiliary and Liver Transplant Surgery, St James's University Hospital, Leeds, UK.
Frederik J H HoogwaterDepartment of Surgery, University Medical Center, Groningen, Groningen, The Netherlands.
William R JarnaginHepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Geert KazemierDepartment of Surgery, Amsterdam UMC, Amsterdam, The Netherlands.
Hauke LangDepartment of General, Visceral and Transplantation Surgery, University Medical Center, Mainz, Germany.
Shishir K MaithelDivision of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Massimo MalagoDepartment of HPB and Liver Transplantation Surgery, University College London, Royal Free Hospitals, London, UK.
Hassan Z MalikAintree University Hospital, Liverpool, UK.
Silvio NadalinDepartment of General and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
Ulf NeumannDepartment of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
Steven W M Olde DaminkDepartment of Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.
Johann PratschkeDepartment of Surgery, Campus Charité Mitte and Campus Virchow-KlinikumCharité-Universitätsmedizin Berlin, Berlin, Germany.
Francesca RattiHepatobiliary Surgery Division, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy.
Matteo RavaioliGeneral Surgery and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Keith J RobertsDepartment of Surgery, University Hospital Birmingham, Birmingham, UK.
Erik SchaddeDepartment of Surgery, Rush University Medical Center Chicago, Chicago, IL, USA.
Andreas A SchnitzbauerUniversitätsklinikum Frankfurt, Klinik für AllgemeinViszeral und Transplantationschirurgie, Frankfurt, Germany.
Ernesto SparrelidDivision of Surgery and Oncology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Baki TopalDepartment of Surgery, Catholic University of Leuven, Leuven, Belgium.
Roberto I TroisiDepartment of Clinical Medicine and Surgery, Division of HBP, Minimally Invasive and Robotic Surgery, Transplantation Service, Federico II University Hospital, Naples, Italy.
Bas Groot KoerkampDepartment of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Perihilar Cholangiocarcinoma Collaboration Group

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundA right- or left-sided liver resection can be considered in about half of patients with perihilar cholangiocarcinoma (pCCA), depending on tumor location and vascular involvement. This study compared postoperative mortality and long-term survival of right- versus left-sided liver resections for pCCA.

methodsPatients who underwent major liver resection for pCCA at 25 Western centers were stratified according to the type of hepatectomy-left, extended left, right, and extended right. The primary outcomes were 90-day mortality and overall survival (OS).

resultsBetween 2000 and 2022, 1701 patients underwent major liver resection for pCCA. The 90-day mortality was 9% after left-sided and 18% after right-sided liver resection (p < 0.001). The 90-day mortality rates were 8% (44/540) after left, 11% (29/276) after extended left, 17% (51/309) after right, and 19% (108/576) after extended right hepatectomy (p < 0.001). Median OS was 30 months (95% confidence interval [CI] 27-34) after left and 23 months (95% CI 20-25) after right liver resection (p < 0.001), and 33 months (95% CI 28-38), 27 months (95% CI 23-32), 25 months (95% CI 21-30), and 21 months (95% CI 18-24) after left, extended left, right, and extended right hepatectomy, respectively (p < 0.001). A left-sided resection was an independent favorable prognostic factor for both 90-day mortality and OS compared with right-sided resection, with similar results after excluding 90-day fatalities.

conclusionsA left or extended left hepatectomy is associated with a lower 90-day mortality and superior OS compared with an (extended) right hepatectomy for pCCA. When both a left and right liver resection are feasible, a left-sided liver resection is preferred.

Indexed as

Bile Duct NeoplasmsHepatectomyKlatskin TumorAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPostoperative ComplicationsPrognosisRetrospective StudiesSurvival Rate

Identifiers

PMID38472674
PMCPMC11164810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.